Physician profile
Hala Boktor
NPI 1386096378
$817.15
in general payments reported to CMS, 2019-2025
10 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $17.00 · 2024: $280 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $642.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $417.24 | 2024-2025 | Opsumit, Uptravi |
| Boston Scientific Corporation | $84.36 | 2021 | |
| Angiodynamics, INC. | $73.29 | 2021 | |
| Ani Pharmaceuticals, INC. | $64.53 | 2024-2025 | Purified Cortrophin Gel |
| Noah Medical Corporation | $58.90 | 2025 | Galaxy |
| Amgen INC. | $47.06 | 2025 | Tezspire |
| Electromed, INC. | $20.56 | 2025 | Smartvest |
| Vertex Pharmaceuticals Incorporated | $17.75 | 2025 | |
| Pfizer INC. | $17.00 | 2022 | |
| Phadia US INC. | $16.46 | 2025 | Immunocap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hala Boktor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.